Brief: PegBio Says PDC Granted Exclusive License For Pb-119 In Middle East And Africa
10/10/2025 11:28
Oct 10 (Reuters) - PegBio Co Ltd 2565.HK: PDC GRANTED EXCLUSIVE LICENSE FOR PB-119 IN MIDDLE EAST AND AFRICA LICENSE INCLUDES REGIONAL DEVELOPMENT AND COMMERCIALIZATION Further company coverage: 2565.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pegbio
See all newsBrief: Pegbio Enters Joint Research And Development Collaboration With SN Bioscience
Brief: Alibaba Health Inks Strategic Tie-Up With Tenry, PegBio To Launch GLP-1RA Drug
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: PegBio Co Posts FY Loss Attributable RMB208.4 Million
PegBio jumps most in 7 months on deal with Shanghai Tenry